Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Allows Telework For Reviewers As Companies Detail Layoff-Related Problems
Apr 10 2025
•
By
Derrick Gingery
FDA reviewers now can telework two days per week.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Pathways & Standards